Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Kintor Pharmaceutical's OCF Margin % or its related term are showing as below:
HKSE:09939'
s OCF Margin % Range Over the Past 10 Years
Min: -16454.22 Med: -3526.62 Max: -519.35
Current: -518.11
During the past 8 years, the highest OCF Margin % of Kintor Pharmaceutical was -519.35%. The lowest was -16454.22%. And the median was -3526.62%.
HKSE:09939's OCF Margin % is ranked worse than 73.63% of 952
companies
in the Biotechnology industry
Industry Median: -68.59
vs HKSE:09939: -518.11
Kintor Pharmaceutical OCF Margin % Related Terms
Kintor Pharmaceutical OCF Margin % Historical Data
* Premium members only.
The historical data trend for Kintor Pharmaceutical's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:09939 vs VRTX, REGN, RVMD: OCF Margin % Comparison
For the Biotechnology subindustry, Kintor Pharmaceutical's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Kintor Pharmaceutical OCF Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Kintor Pharmaceutical's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Kintor Pharmaceutical's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Kintor Pharmaceutical (HKSE:09939) has a OCF Margin % of -375.37% as of Dec. 2025. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Kintor Pharmaceutical and its competitors. According to the industry distribution chart, Kintor Pharmaceutical ranks #701 out of 952 companies in the Biotechnology industry, placing it in the top 73.6%.
Is Kintor Pharmaceutical's OCF Margin % too high?
Kintor Pharmaceutical's current OCF Margin % is -375.37%. Based on the distribution chart, Kintor Pharmaceutical ranks #701 out of 952 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Kintor Pharmaceutical has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Kintor Pharmaceutical's OCF Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Kintor Pharmaceutical ranks #701 out of 952 companies for OCF Margin %. This places Kintor Pharmaceutical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Kintor Pharmaceutical and its competitors. Kintor Pharmaceutical's current OCF Margin % is -375.37%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kintor Pharmaceutical stock overvalued right now?
Kintor Pharmaceutical (HKSE:09939) has a current OCF Margin % of -375.37%. The current OCF Margin % is -375.37%. Kintor Pharmaceutical's overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Kintor Pharmaceutical (HKSE:09939), the current OCF Margin % is -375.37% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Kintor Pharmaceutical Ltd is a clinical-stage novel drug developer in China, focusing on developing therapeutic drugs for unmet medical needs. Its pipelines cover indications of dermatology, such as AGA and acne vulgaris, and indications of tumors, catering to the unmet medical needs of patients and cosmetics consumers globally. The Group's cosmetic product types include anti-hair loss, acne treatment, and skin whitening products. Kintor's pipeline consists of various drug candidates such as KX-826, AR-PROTAC Compound (GT20029), GT1708F (Hedgehog/SMO Inhibitor), GT0486, and ALK-1 Antibody (GT90001). It has only one reportable operating segment, which is engaged in the research and development of medicine products and extends to functional cosmetics and raw materials.
25GF Score
Get the complete analysis for HKSE:09939
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:09939 has been successfully added to your 
